NEW YORK (GenomeWeb) – Rennova Health subsidiary Medytox Diagnostics has partnered with Genomas to launch a series of pharmacogenetics tests to determine a patient's capacity to metabolize certain drugs and potentially tailor treatments to an individual's specific genetic makeup.

The tests they will be performed via a US Food and Drug Administration-approved in vitro diagnostic (IVD) genotyping kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.